Basic scientists honored for outstanding contributions in biochemistry, transcription, genomics and systems biology, and pathbreaking studies in the field of oncogenes
The $100,000 one-year grant will fund the development of a new class of antimicrobial drugs to treat TB and limit the evolution of resistance to antibiotics